SG43180A1 - Process for conditioning of water-soluble substan ces - Google Patents

Process for conditioning of water-soluble substan ces

Info

Publication number
SG43180A1
SG43180A1 SG1996004975A SG1996004975A SG43180A1 SG 43180 A1 SG43180 A1 SG 43180A1 SG 1996004975 A SG1996004975 A SG 1996004975A SG 1996004975 A SG1996004975 A SG 1996004975A SG 43180 A1 SG43180 A1 SG 43180A1
Authority
SG
Singapore
Prior art keywords
water
conditioning
soluble
vacuum
micronised
Prior art date
Application number
SG1996004975A
Other languages
English (en)
Inventor
Kartarina Stora Vanern Bystrom
Edib Jakupovic
Eva Trofast
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20382434&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG43180(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Ab filed Critical Astra Ab
Publication of SG43180A1 publication Critical patent/SG43180A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Detergent Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Paper (AREA)
  • Treating Waste Gases (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Hydrogenated Pyridines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
  • Cephalosporin Compounds (AREA)
SG1996004975A 1991-04-11 1992-03-24 Process for conditioning of water-soluble substan ces SG43180A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9101090A SE9101090D0 (sv) 1991-04-11 1991-04-11 Process for conditioning of water-soluble substances

Publications (1)

Publication Number Publication Date
SG43180A1 true SG43180A1 (en) 1997-10-17

Family

ID=20382434

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996004975A SG43180A1 (en) 1991-04-11 1992-03-24 Process for conditioning of water-soluble substan ces

Country Status (28)

Country Link
US (1) US5562923A (https=)
EP (3) EP0680752B1 (https=)
JP (2) JP3400999B2 (https=)
KR (1) KR100216384B1 (https=)
AT (2) ATE137671T1 (https=)
AU (1) AU662519B2 (https=)
BG (1) BG61474B1 (https=)
CA (1) CA2106975C (https=)
CZ (1) CZ286936B6 (https=)
DE (2) DE69232207T2 (https=)
DK (2) DK0580648T3 (https=)
EE (1) EE02970B1 (https=)
ES (2) ES2086733T3 (https=)
FI (1) FI105388B (https=)
GR (1) GR3020602T3 (https=)
HK (1) HK52497A (https=)
HU (1) HU211116B (https=)
IE (1) IE921144A1 (https=)
IS (1) IS3834A (https=)
NO (1) NO311867B1 (https=)
PL (1) PL168232B1 (https=)
PT (1) PT680752E (https=)
RO (1) RO115779B1 (https=)
RU (1) RU2112507C1 (https=)
SE (1) SE9101090D0 (https=)
SG (1) SG43180A1 (https=)
SK (1) SK280310B6 (https=)
WO (1) WO1992018110A1 (https=)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874063A (en) * 1991-04-11 1999-02-23 Astra Aktiebolag Pharmaceutical formulation
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
US5980949A (en) * 1994-10-03 1999-11-09 Astra Aktiebolag Formulation for inhalation
US5983956A (en) * 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
DK0812195T3 (da) 1995-02-28 2003-03-03 Aventis Pharma Inc Farmaceutisk sammensætning til piperidinoalkanolforbindelser
US5654007A (en) * 1995-06-07 1997-08-05 Inhale Therapeutic Systems Methods and system for processing dispersible fine powders
GB9526392D0 (en) * 1995-12-22 1996-02-21 Glaxo Group Ltd Medicaments
SE9700133D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
WO1998041193A1 (en) * 1997-03-20 1998-09-24 Schering Corporation Preparation of powder agglomerates
US6503537B2 (en) 1997-03-20 2003-01-07 Schering Corporation Preparation of powder agglomerates
US6495167B2 (en) 1997-03-20 2002-12-17 Schering Corporation Preparation of powder agglomerates
JP4344405B2 (ja) * 1997-08-26 2009-10-14 アベンティス・ファーマスーティカルズ・インコーポレイテッド ピペリジノアルカノール−鬱血除去剤の組合せ用医薬組成物
AU756693B2 (en) * 1997-09-29 2003-01-23 Novartis Ag Stabilized bioactive preparations and methods of use
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
FI105074B (fi) * 1997-12-31 2000-06-15 Leiras Oy Farmaseuttisen formulaation valmistusmenetelmä
US6287693B1 (en) * 1998-02-25 2001-09-11 John Claude Savoir Stable shaped particles of crystalline organic compounds
SE9804000D0 (sv) 1998-11-23 1998-11-23 Astra Ab New composition of matter
GB9826284D0 (en) 1998-12-01 1999-01-20 Rhone Poulence Rorer Limited Process
GB9826286D0 (en) * 1998-12-01 1999-01-20 Rhone Poulence Rorer Limited Process
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
AR022695A1 (es) * 1999-01-28 2002-09-04 Schering Corp PORTADOR SoLIDO PARTICULADO Y MÉTODO PARA PROVEER CONTROL DE LA PARTICULADA PARA LA DISTRIBUCIoN DE TAMANO DE PARTíCULAS Y DE CONTENIDO AMORFO CONVERTIBLE DURANTE SU PREPARACION
US6623760B1 (en) 1999-01-28 2003-09-23 Schering Corporation Method of preparing particles for agglomeration
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US7309707B2 (en) 2002-03-20 2007-12-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
US7244415B2 (en) 2002-03-28 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations of an anhydrate
US20040028746A1 (en) * 2002-08-06 2004-02-12 Sonke Svenson Crystalline drug particles prepared using a controlled precipitation (recrystallization) process
GB0228826D0 (en) * 2002-12-11 2003-01-15 Okpala Joseph Hair technology in creating particles with improved delivery capabilities
ES2233227T1 (es) * 2003-03-26 2005-06-16 Teva Pharmaceutical Industries Ltd. Procedimiento para la preparacion de ingredientes farmaceuticos activos con un area superficial especifica.
CA2528545C (en) * 2003-06-13 2014-08-12 John Claude Savoir Process for the manufacture of stable shaped particles consisting of estradiol and cholesterol
GB0323684D0 (en) 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
BRPI0415579A (pt) * 2003-10-17 2007-01-02 Du Pont estrutura em multicamadas, embalagem e processo
WO2005074893A1 (en) 2004-02-03 2005-08-18 Chemagis Ltd. Stable amorphous forms of montelukast sodium
DE102004048390A1 (de) 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Pulverinhalativa auf Basis modifizierter Laktosemischungen als Hilfsstoff
DE102004048389A1 (de) 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Modifizierung von Oberflächen von Laktose als Hilfsstoff zur Verwendung für Pulverinhalativa
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
ES2396471T3 (es) * 2007-12-13 2013-02-21 Novartis Ag Procedimiento para reducir la tendencia de una sal de glicopirronio a agregarse durante el almacenamiento
RU2376079C1 (ru) * 2008-06-11 2009-12-20 Государственное образовательное учреждение высшего профессионального образования "Московский государственный университет инженерной экологии" Способ получения порошков микронизированных частиц
GB0918149D0 (en) 2009-10-16 2009-12-02 Jagotec Ag Improved medicinal aerosol formulation
WO2011110852A1 (en) 2010-03-10 2011-09-15 Astrazeneca Ab Polymorphic forms of 6- [2- (4 -cyanophenyl) - 2h - pyrazol - 3 - yl] - 5 -methyl - 3 - oxo - 4 - (trifluoromethyl - phenyl) 3,4-dihydropyrazine-2-carboxylic acid ethylamide
JP2014527955A (ja) 2011-06-29 2014-10-23 アストラゼネカ・アクチエボラーグＡｓｔｒａｚｅｎｅｃａ Ａｋｔｉｅｂｏｌａｇ 糖質コルチコイド介在性障害の処置のための、インダゾリルアミド誘導体の結晶形
SG11201507286QA (en) * 2013-03-15 2015-10-29 Pearl Therapeutics Inc Methods and systems for conditioning of particulate crystalline materials
WO2021219230A1 (en) 2020-04-30 2021-11-04 Paolo Fiorina Antiviral treatment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3978192A (en) * 1971-09-23 1976-08-31 Sussman Martin V Method of drawing fibers using a microterraced drawing surface
US4405598A (en) * 1976-01-30 1983-09-20 Fisons, Limited Composition for treating asthma
KR890000664B1 (ko) * 1981-10-19 1989-03-22 바리 안소니 뉴우샘 미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법
US4476130A (en) * 1982-09-09 1984-10-09 Riker Laboratories, Inc. 3-(1H-Tetrazol-5-yl)-4H-pyrimido[2,1-b]benzoxazol-4-one compounds exhibiting anti-allergic activity
EP0258258B1 (de) * 1985-06-21 1989-03-29 Gergely, Gerhard, Dr. Verfahren und vorrichtung zur behandlung von prozessgut, sowie mit hilfe des verfahrens und/oder der vorrichtung hergestelltes reaktivprodukt
IT1204826B (it) * 1986-03-04 1989-03-10 Chiesi Farma Spa Composizioni farmaceutiche per inalazione
KR100229754B1 (ko) * 1989-11-24 1999-11-15 샬러 한스, 하우스 한스 루돌프 판크레아틴구형입자, 이의 제조방법 및 이를 함유하는 약제학적 조성물
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles

Also Published As

Publication number Publication date
CA2106975C (en) 2002-03-19
PT680752E (pt) 2002-05-31
BG61474B1 (en) 1997-09-30
SK280310B6 (sk) 1999-11-08
HU211116B (en) 1995-10-30
DK0580648T3 (da) 1996-09-16
AU662519B2 (en) 1995-09-07
EE02970B1 (et) 1997-04-15
ATE137671T1 (de) 1996-05-15
EP0680752A2 (en) 1995-11-08
EP0580648A1 (en) 1994-02-02
HK52497A (en) 1997-05-02
FI105388B (fi) 2000-08-15
ATE208613T1 (de) 2001-11-15
CA2106975A1 (en) 1992-10-12
HU9302870D0 (en) 1993-12-28
SK108893A3 (en) 1994-03-09
CZ286936B6 (cs) 2000-08-16
FI934429L (fi) 1993-10-08
GR3020602T3 (en) 1996-10-31
DE69210601D1 (de) 1996-06-13
IE921144A1 (en) 1992-10-21
HUT65095A (en) 1994-04-28
US5562923A (en) 1996-10-08
IS3834A (is) 1992-10-12
DK0680752T3 (da) 2002-02-25
DE69210601T2 (de) 1996-10-02
ES2086733T3 (es) 1996-07-01
SE9101090D0 (sv) 1991-04-11
JP3400999B2 (ja) 2003-04-28
KR100216384B1 (ko) 1999-08-16
BG98147A (bg) 1994-12-02
EP0508969A1 (en) 1992-10-14
NO311867B1 (no) 2002-02-11
FI934429A0 (fi) 1993-10-08
WO1992018110A1 (en) 1992-10-29
RU2112507C1 (ru) 1998-06-10
EP0680752B1 (en) 2001-11-14
NO933575L (no) 1993-10-06
JP2003155228A (ja) 2003-05-27
RO115779B1 (ro) 2000-06-30
AU1534792A (en) 1992-11-17
CZ211693A3 (en) 1994-04-13
JPH06506454A (ja) 1994-07-21
EP0580648B1 (en) 1996-05-08
EP0680752A3 (https=) 1995-11-22
DE69232207D1 (de) 2001-12-20
PL168232B1 (pl) 1996-01-31
NO933575D0 (no) 1993-10-06
DE69232207T2 (de) 2002-08-01
ES2168322T3 (es) 2002-06-16

Similar Documents

Publication Publication Date Title
SG43180A1 (en) Process for conditioning of water-soluble substan ces
RU93058260A (ru) Способ получения водорастворимых микронизированных веществ
AU655644B2 (en) Process for impregnation and expansion of tobacco
JPS5222578A (en) Stabilizing agent for organic materials
AR004487A1 (es) Metodo para preparar una composicion fitoactiva seca de n-fosfono- metilglicina de amonio
HUT55517A (en) Shaped bodies for heat-insulating purpose
ITMI911038A1 (it) Processo per l'assorbimento di gas residui, in particolare azoto, mediante una lega getter a base di bario non evaporato.
IL90242A0 (en) A process for drying water-wet polycarbonate membranes
IT7885588A0 (it) Mezzo propellente adinfiammabilita' ridotta per aerosol, procedimento per la suaproduzione e dispositivo per la realizzazione del procedimento.
JPS51117991A (en) A process for producing oxygen absorbent
JPS5241192A (en) Process for concentrating or storing ozone by adsorption
ES2145760T3 (es) Procedimiento para la fijacion de asas a recipientes de metal y dispositivo para la realizacion del procedimiento.
JPS5281078A (en) Permeable membrane module
EP1059166B8 (en) Method and apparatus for drying printed materials
RU96109577A (ru) Способ проведения оксигенобаротерапии в барокамерах с автономной системой дыхания
GB2019869A (en) Process for the manufacture of 1,2-diaminoanthraquinone
JPS51131458A (en) A process for treatment of high temperature high pressure exhaust gas
JPS526738A (en) Crosslinkable coating materials
JPS5421211A (en) Error correction decoder for differential code
JPS5257511A (en) Cylindrical body correcting device
JPS523372A (en) Sealing method of closed glass container
JPS51137073A (en) A liquid pressure control apparatus
JPS51124989A (en) Sampling apparatus for liquid
ITBZ930029A1 (it) Dispositivo reggibersaglio per tiro a segno con trasporto pneumatico del bersaglio.
GB2012289A (en) Coating composition for release sheets